type2diabetes

We caught up with Amit Shah and he discussed Virta's mission to reverse Type 2 diabetes and obesity through personalized nutrition and continuous remote monitoring. He also discusses he challenges of scaling Virta's pioneering clinical, technology, and business model - including evolving massive workflows and systems amid rapid growth and how recent GLP-1 obesity drug approvals are tailwinds driving adoption of Virta’s more sustainable, cost-effective solution.

Amit Shah: https://www.linkedin.com/in/amitrshah1/

Chris Hoyd: https://www.linkedin.com/in/chrishoyd/

For the full YouTube video: https://youtu.be/Fl-_SsHEz0Y

Virta Health Website: https://www.virtahealth.com/

Virta Health YouTube: https://www.youtube.com/virtahealth

Product in Healthtech is community for healthtech product leaders, by product leaders. For more information, and to sign up for our free webinars, visit www.productinhealthtech.com.

Introduction 00:00 - 07:00

Grahams personal/professional journey 08:55 - 24:00 

Low carb isn't just about weight loss 25:40 - 32:40 

How do pharmacy systems differ in the US and the UK 32:54 - 38:16 

A reverse take over of general practice medicine 38:36 - 43:24 

How are we receiving the best care when doctors prescribing medication have so much work? 44:05 - 45:32 

How Prolongevity is changing the paradigm 45:42 - 50:00 

Modern medicine not addressing root cause of illnesses 50:10 - 54:38

What is Graham's diet and the glycaemic index 54:40 - 62:45

In this episode, Christa goes over the new "medication rage": Ozempic. She shares the research, and her thoughts on weight loss, type 2 diabetes, and what to consider when thinking of taking the medication.

Key Topics: 

• (0:40) Response to the New York Times Article "Ozempic Can Cause Major Weight Loss. What Happens if You Stop Taking It?"
• (1:43) What is Ozempic? And how does it help someone living with Type 2 Diabetes? 
• (4:24) What is causing the weight loss? 
• (4:55) The major side effects of taking Ozempic. Are they good or bad?
• (6:47) Advantages to taking Ozempic and what it does for your Type 2 Diabetes. 
• (8:24) Let's go to the research and see what happens when you come off Ozempic. 
• (12:10) Lead researcher Domenica Rubino who conducted another study said in an interview that "...long-term treatment is needed to avoid weight regain. Weight regulation is incredibly complicated. It’s complicated physiology and there are all kinds of hormonal impacts that drive regain..."
• (12:45) Christa's response to why she disagrees and how researchers need to start analyzing other factors leading into treatment and post-treatment with Ozempic. Ozempic is also a medication used to help with blood sugar, the extra "perk" is weight loss. 
• (14:07) Are we treating the person as a whole which includes an individuals lifestyle, stress factors, sleeping habits, eating patterns, and emotional state?

Come follow along and don't forget to subscribe!
Want to see what a Blood Sugar Stabilizing Meal Plan looks like? Get it by clicking here
Website: https://christabrowndietitian.com/
YouTube: https://www.youtube.com/channel/UC8Nqc4Yx-R56kSXe_tUUw0Q
Instagram: https://www.instagram.com/t2.diabetes.dietitian/
Pinterest: https://www.pinterest.com/type2diabetesnutrition/
Email: christa@christabrowndietitian.com

Matt Pattison steps aside from his role as the one asking the questions, to the one answering them. In this episode, Martin Sadofski (screenwriter) asks Pattison, 'what have you learnt so far from interviewing such a broad range of guests.' On one hand we've had guests designing PPE, to the other hand modelling likely deaths, and the impact of obesity and diabetes in the battle with the coronavirus.

Do you have an idea that could help us fight the Coronavirus after lockdown? Join us on COVID-19 Side effects. Email hello@weareten.co.uk

Dr Aseem Malhotra is an NHS Consultant Cardiologist, and world renowned expert in the prevention, diagnosis and management of heart disease. He is a founding member of Action on Sugar and was the lead campaigner highlighting the harm caused by excess sugar consumption in the United Kingdom, particularly its role in type 2 diabetes and obesity. He is now advising the Health Secretary, Matt Hancock  about the links between obesity and metabolic syndrome and Covid-19 deaths.

I had the pleasure of talking with Aseem about the UK obesity crisis, the definitions of metabolic syndrome and why, in a very clear way, it's not too late for us all.

Do you have an idea that could help us fight the Coronavirus after lockdown? Join us on COVID-19 Side effects. Email hello@weareten.co.uk

More info > Women's Health-Diabetes

Join the Facebook group at @Betweenatalkandahardplace
Follow me on Instagram @lifelessonsandlovesessions
Submit questions at www.lifelessonsandlovesessions.com
Email: betweenatalkandahardplace@gmail.com 
Social Media Hashtag #betweenatalkandahardplace

Did you know that if you are a diabetic, your risk for cancer increases? With 65 million diabetics across India and type II diabetes damaging our eyes, kidneys, organs and causing nerve damage, increasing the risk of heart disease, it is time to stand up to say no to type II diabetes.

This week on Heal and Hearty, host Rachna Chhachhi is joined by two diabetes patients who have made serious lifestyle changes and reversed their type II diabetes as well as their risk of all these diseases. Meet executive chef of Taj lands end, Bandra West, Mumbai, Chef Anirudhya Roy, and technology entrepreneur, Uday Nayak who shared their type II diabetes reversal journeys with Rachna and you. Listen to the tips and don't forget to tune in to the questions at the end of the show chosen from messages to @RachnaRestores Instagram followers! It could be your question being featured on our show. You can listen to this show and other awesome shows on the IVM Podcasts app on Android: https://ivm.today/android or iOS: https://ivm.today/ios, or any other podcast app.

You can check out our website at http://www.ivmpodcasts.com/

See omnystudio.com/listener for privacy information.